vs
NATIONAL PRESTO INDUSTRIES INC（NPK）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
NATIONAL PRESTO INDUSTRIES INC的季度营收约是再鼎医药的1.3倍（$164.0M vs $127.1M），NATIONAL PRESTO INDUSTRIES INC同比增速更快（21.7% vs 17.1%），NATIONAL PRESTO INDUSTRIES INC自由现金流更多（$12.4M vs $-26.7M），过去两年NATIONAL PRESTO INDUSTRIES INC的营收复合增速更高（46.3% vs 20.8%）
National Presto Industries创始于1905年，总部位于美国威斯康星州欧克莱尔，历经多次更名后于1953年确定现用名。该公司最初生产商用及后续家用压力锅，自1939年起推出小型家用烹饪电器，1969年在纽约证券交易所上市。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
NPK vs ZLAB — 直观对比
营收规模更大
NPK
是对方的1.3倍
$127.1M
营收增速更快
NPK
高出4.6%
17.1%
自由现金流更多
NPK
多$39.1M
$-26.7M
两年增速更快
NPK
近两年复合增速
20.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $164.0M | $127.1M |
| 净利润 | — | — |
| 毛利率 | 16.9% | 51.0% |
| 营业利润率 | 11.4% | -54.6% |
| 净利率 | — | — |
| 营收同比 | 21.7% | 17.1% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NPKZLAB
| Q4 25 | $164.0M | $127.1M | ||
| Q3 25 | $115.5M | $115.4M | ||
| Q2 25 | $120.4M | $109.1M | ||
| Q1 25 | $103.6M | $105.7M | ||
| Q4 24 | $134.7M | $108.5M | ||
| Q3 24 | $91.8M | $101.8M | ||
| Q2 24 | $85.1M | $100.1M | ||
| Q1 24 | $76.7M | $87.1M |
净利润NPKZLAB
| Q4 25 | — | — | ||
| Q3 25 | $5.3M | $-36.0M | ||
| Q2 25 | $5.2M | $-40.7M | ||
| Q1 25 | $7.6M | $-48.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $8.1M | $-41.7M | ||
| Q2 24 | $6.1M | $-80.3M | ||
| Q1 24 | $6.6M | $-53.5M |
毛利率NPKZLAB
| Q4 25 | 16.9% | 51.0% | ||
| Q3 25 | 13.9% | 59.5% | ||
| Q2 25 | 15.4% | 60.6% | ||
| Q1 25 | 17.5% | 63.6% | ||
| Q4 24 | 24.3% | 61.5% | ||
| Q3 24 | 18.8% | 64.1% | ||
| Q2 24 | 17.3% | 64.9% | ||
| Q1 24 | 18.1% | 61.4% |
营业利润率NPKZLAB
| Q4 25 | 11.4% | -54.6% | ||
| Q3 25 | 5.6% | -42.3% | ||
| Q2 25 | 5.1% | -50.3% | ||
| Q1 25 | 8.8% | -53.3% | ||
| Q4 24 | 17.3% | -62.6% | ||
| Q3 24 | 10.0% | -66.6% | ||
| Q2 24 | 7.5% | -76.0% | ||
| Q1 24 | 8.2% | -80.7% |
净利率NPKZLAB
| Q4 25 | — | — | ||
| Q3 25 | 4.6% | -31.2% | ||
| Q2 25 | 4.3% | -37.3% | ||
| Q1 25 | 7.3% | -45.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.8% | -40.9% | ||
| Q2 24 | 7.1% | -80.2% | ||
| Q1 24 | 8.6% | -61.4% |
每股收益（稀释后）NPKZLAB
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $-0.04 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | — | $-0.04 | ||
| Q2 24 | — | $-0.08 | ||
| Q1 24 | — | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.8M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $395.1M | $715.5M |
| 总资产 | $500.7M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NPKZLAB
| Q4 25 | $3.8M | $689.6M | ||
| Q3 25 | $4.6M | $717.2M | ||
| Q2 25 | $4.8M | $732.2M | ||
| Q1 25 | $5.5M | $757.3M | ||
| Q4 24 | $22.7M | $779.7M | ||
| Q3 24 | $33.2M | $616.1M | ||
| Q2 24 | $53.4M | $630.0M | ||
| Q1 24 | $87.9M | $650.8M |
股东权益NPKZLAB
| Q4 25 | $395.1M | $715.5M | ||
| Q3 25 | $379.8M | $759.9M | ||
| Q2 25 | $374.1M | $791.7M | ||
| Q1 25 | $368.6M | $810.8M | ||
| Q4 24 | $367.6M | $840.9M | ||
| Q3 24 | $346.6M | $667.7M | ||
| Q2 24 | $338.1M | $704.2M | ||
| Q1 24 | $331.6M | $762.2M |
总资产NPKZLAB
| Q4 25 | $500.7M | $1.2B | ||
| Q3 25 | $503.8M | $1.2B | ||
| Q2 25 | $471.9M | $1.2B | ||
| Q1 25 | $455.3M | $1.2B | ||
| Q4 24 | $453.4M | $1.2B | ||
| Q3 24 | $428.9M | $985.3M | ||
| Q2 24 | $418.1M | $987.4M | ||
| Q1 24 | $417.5M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.9M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $12.4M | $-26.7M |
| 自由现金流率自由现金流/营收 | 7.6% | -21.0% |
| 资本支出强度资本支出/营收 | 0.9% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-36.2M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流NPKZLAB
| Q4 25 | $13.9M | $-26.0M | ||
| Q3 25 | $-24.6M | $-32.0M | ||
| Q2 25 | $-10.9M | $-31.0M | ||
| Q1 25 | $12.5M | $-61.7M | ||
| Q4 24 | $-7.6M | $-55.8M | ||
| Q3 24 | $-17.5M | $-26.8M | ||
| Q2 24 | $-33.9M | $-42.2M | ||
| Q1 24 | $5.6M | $-90.1M |
自由现金流NPKZLAB
| Q4 25 | $12.4M | $-26.7M | ||
| Q3 25 | $-24.7M | $-35.0M | ||
| Q2 25 | $-13.4M | $-33.9M | ||
| Q1 25 | $-10.5M | $-63.2M | ||
| Q4 24 | $-11.3M | $-58.4M | ||
| Q3 24 | $-20.3M | $-28.2M | ||
| Q2 24 | $-34.5M | $-42.9M | ||
| Q1 24 | $5.2M | $-91.1M |
自由现金流率NPKZLAB
| Q4 25 | 7.6% | -21.0% | ||
| Q3 25 | -21.4% | -30.4% | ||
| Q2 25 | -11.1% | -31.1% | ||
| Q1 25 | -10.2% | -59.9% | ||
| Q4 24 | -8.4% | -53.8% | ||
| Q3 24 | -22.1% | -27.7% | ||
| Q2 24 | -40.6% | -42.9% | ||
| Q1 24 | 6.7% | -104.5% |
资本支出强度NPKZLAB
| Q4 25 | 0.9% | 0.5% | ||
| Q3 25 | 0.1% | 2.6% | ||
| Q2 25 | 2.0% | 2.6% | ||
| Q1 25 | 22.2% | 1.5% | ||
| Q4 24 | 2.7% | 2.4% | ||
| Q3 24 | 3.1% | 1.3% | ||
| Q2 24 | 0.8% | 0.7% | ||
| Q1 24 | 0.5% | 1.1% |
现金转化率NPKZLAB
| Q4 25 | — | — | ||
| Q3 25 | -4.63× | — | ||
| Q2 25 | -2.12× | — | ||
| Q1 25 | 1.64× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -2.16× | — | ||
| Q2 24 | -5.58× | — | ||
| Q1 24 | 0.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NPK
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
